High positive predictive value of PAPP-A for acute coronary syndrome diagnosis in heparin-naïve patients
- 122 Downloads
Pregnancy-associated plasma protein-A (PAPP-A) was studied as a marker of acute coronary syndrome (ACS). It has been shown that its levels are increased by heparin administration. Therefore, the aim of our study was to ascertain the diagnostic significance of PAPP-A in heparin-naïve patients and compare it with (TnI). We prospectively studied 67 heparin-naïve patients with acute chest pain. The patients were independently grouped according to the presence or absence of ACS. PAPP-A levels were significantly increased in ACS patients (8.6 vs. 7.3 mIU/l; P = 0.006) with high positive (95.7%) and lower negative predictive values (47.7%). In multivariate analysis, its levels were strongly predictive of a final diagnosis of ACS (OR 41.8; 95th CI 2.64–662.6; P = 0.008). The diagnostic significance of PAPP-A was not higher than TnI even within 6 h after the onset of chest pain [the area under the ROC curve (AUC) was 0.69 for PAPP-A and 0.91 for TnI, respectively; P = 0.08]. We observed no difference in the AUC in NSTE-ACS patients (0.73 for PAPP-A and 0.79 for TnI (P = 0.5)). PAPP-A levels were an independent predictor of ACS diagnosis in heparin-naïve patients. Its diagnostic significance was not higher than TnI even within a short period after the onset of chest pain. In troponin-negative NSTE-ACS patients, PAPP-A helped make the correct final diagnosis.
KeywordsAcute coronary syndrome Pregnancy-associated plasma protein-A Troponin Diagnostic significance
Supported by the MZOFNM 2005 from the Czech Ministry of Health. The cooperation of the staff of the Emergency Department of Motol University Hospital and the Emergency Department of Kladno District Hospital is highly appreciated.
- 14.Hájek P, Macek M, Lashkevich A et al (2010) The increase of pregnancy associated plasma protein-A is directly linked to heparin administration not only to acute coronary syndrome. Eur Heart J 31(Abstract Suppl):193Google Scholar
- 20.Apple FS, Wu AH, Mair J, Ravkilde J, Panteghini M, Tate J, Pagani F, Christenson RH, Mockel M, Danne O, Jaffe AS, Committee on standardization of markers of cardiac damage of the IFCC (2005) Future biomarkers for detection of ischemia and risk stratification in acute coronary syndrome. Clin Chem 51:810–824PubMedCrossRefGoogle Scholar